XML 68 R61.htm IDEA: XBRL DOCUMENT v3.24.2
Financial instruments (Tables)
12 Months Ended
Mar. 31, 2024
Fair Value Disclosures [Abstract]  
Schedule of Financial Instruments Measured at Fair Value on Recurring Basis

 

 

 

 

 

March 31, 2024

 

 

 

 

Fair Value Measured using

 

 

 

 

Particulars

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 Financial liabilities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Derivative warrant liabilities

 

 

 

 

5,585,955

 

 

 

-

 

 

 

-

 

 

 

5,585,955

 

 Convertible debentures

 

 

 

 

-

 

 

 

-

 

 

 

1,374,481

 

 

 

1,374,481

 

 

 

 

 

5,585,955

 

 

 

-

 

 

 

1,374,481

 

 

 

6,960,436

 

 

 

 

 

March 31, 2024

 

 

 

 

Fair Value Measured using

 

 Particulars

 

 

 

Level 1

 

 

Level 2

 

 

Level 3

 

 

Total

 

 Financial assets:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 Forward purchase agreement

 

 

 

 

 

 

 

-

 

 

 

28,784,993

 

 

 

28,784,993

 

 

 

 

 

 

-

 

 

 

-

 

 

 

28,784,993

 

 

 

28,784,993

 

Schedule of Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation

The following table presents a reconciliation of the Company’s Level 3 financial instruments measured and recorded at fair value on a recurring basis as of March 31, 2024:

 

 

 

 

 

Financial asset

 

 

Financial liability

 

 

 

Forward purchase agreement

 

 

Convertible debentures

 

Balance as of March 31, 2023

 

 

-

 

 

 

-

 

Initial measurement

 

 

 

 

46,190,195

 

 

 

1,100,000

 

 Change in fair value

 

 

 

 

(13,614,569

)

 

 

274,481

 

Value of shares sold in Forward Purchase Agreement

 

 

 

 

(3,790,633

)

 

 

-

 

 Balance as of March 31, 2024

 

 

 

 

28,784,993

 

 

 

1,374,481